Viewing Study NCT01271166


Ignite Creation Date: 2025-12-24 @ 4:32 PM
Ignite Modification Date: 2025-12-30 @ 1:56 AM
Study NCT ID: NCT01271166
Status: TERMINATED
Last Update Posted: 2011-01-06
First Post: 2011-01-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: GlivecĀ® Plus m-FOLFOX AvastinĀ® in Advanced Colorectal Cancer
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module